Invitation to media, investor and analyst call for Medicover IFRS 16 restatement

Medicover (MCOV B) will publish an IRFS 16 restatement on 17 April at 08.00 CEST.

The Company will hold a conference call for media, financial analysts and investors on 17 April at 14.30 CEST.

CFO Joe Ryan will present the IFRS 16 restatement and take questions.

Shortly before the webcast presentation slides will be available on our website.

To join the conference call please dial-in using the following details at least 10 minutes before the start of the call:

Sweden: +46 (0) 850 692 185

UK: +44 (0) 203 009 5710

Germany: +49 (0) 692 222 4910

Code: 5152879

A live audio webcast of the conference call will be available at:

https://edge.media-server.com/m6/p/whbp6u3y

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

Phone: +46 703 033 272
Mail: hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenues around €672 million and 20,970 employees. For more information, go to www.medicover.com

About Us

Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.